Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Circulation

• Publication date

  1998-08-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.98.6.580PMID 9714116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries.

  1998cited by this paper
• Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs.

  1997cited by this paper
• Predictors of luminal narrowing by neointima after angioplasty in atherosclerotic rabbits.

  1997cited by this paper
• In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X.

  1996cited by this paper
• Effectiveness of hirulog in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.

  1996cited by this paper
• Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina.

  1996cited by this paper
• Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits.

  1996cited by this paper
• Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes.

  1996cited by this paper
• Procoagulant human monocytes mediate tissue factor/factor VIIa-dependent platelet-thrombus formation when exposed to flowing nonanticoagulated human blood.

  1995cited by this paper
• Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model.

  1995cited by this paper
• Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits.

  1995cited by this paper
• A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries.

  1994cited by this paper
• Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina.

  1994cited by this paper
• Clinical and angiographic outcome after directional coronary atherectomy. A qualitative and quantitative analysis using coronary arteriography and intravascular ultrasound.

  1993cited by this paper
• Tissue factor regulation in vascular smooth muscle: a summary of studies performed using in vivo and in vitro models.

  1993cited by this paper
• Tissue factor is rapidly induced in arterial smooth muscle after balloon injury.

  1993cited by this paper
• Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation.

  1993cited by this paper
• Response of femoral arteries of cholesterol-fed rabbits to balloon angioplasty with or without laser: emphasis on the distribution of foam cells.

  1993cited by this paper
• The tissue factor pathway of blood coagulation.

  1992cited by this paper
• The tissue factor pathway of blood coagulation.

  1992cited by this paper
• Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.

  1991cited by this paper
• The Structural Biology of Expression and Function of Tissue Factor

  1991cited by this paper
• Effectiveness of Recombinant Desulphatohirudin in Reducing Restenosis After Balloon Angioplasty of Atherosclerotic Femoral Arteries in Rabbits

  1991cited by this paper
• Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody.

  1990cited by this paper
• A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor

  1989cited by this paper
• Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

  1989cited by this paper
• Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

  1989cited by this paper
• Selective Cellular Expression ofTissue Factor inHumanTissues

  1989cited by this paper
• Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty. A study in the atherosclerotic rabbit.

  1989cited by this paper
• Tissue factor and hemostasis.

  1988cited by this paper
• Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.

  1985cited by this paper
• Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

  1977cited by this paper
• Demonstration of all connective tissue elements in a single section; pentachrome stains.

  1955cited by this paper
• Demonstration of all connective tissue elements in a single section; pentachrome stains.

  1955cited by this paper

• Endothelial-derived microvesicles promote pro-migratory cross-talk with smooth muscle cells by a mechanism requiring tissue factor and PAR2 activation

  2024influential citation
• The quest for effective pharmacological suppression of neointimal hyperplasia.

  2020cites this paper
• LIM-only protein FHL2 attenuates vascular tissue factor activity, inhibits thrombus formation in mice and FHL2 genetic variation associates with human venous thrombosis

  2019cites this paper
• Bivalirudin Inhibits Thrombin-Mediated Tissue Factor Expression in Human Endothelial Cells

  2017cites this paper
• Correlation of mechanical stresses with arterial disease frequency in animal models

  2015cites this paper
• Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression

  2014cites this paper
• The role of tissue factor in normal pregnancy and in the development of preeclampsia: A review.

  2014cites this paper
• Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression.

  2014cites this paper
• Atherosclerotic plaque identification by virtual histology intravascular ultrasound in a rabbit abdominal aorta model of vulnerable plaque

  2013cites this paper
• Models for the Study of Atherosclerosis and Thrombosis

  2013cites this paper
• Potent cardioprotection from ischemia–reperfusion injury by a two‐domain fusion protein comprising annexin V and Kunitz protease inhibitor

  2013cites this paper
• Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells.

  2013cites this paper
• A novel model of intimal hyperplasia with graded hypoosmotic damage.

  2012cites this paper
• Targeted Treatments for Restenosis and Vein Graft Disease

  2012cites this paper
• Atherosclerosis and Thrombosis: Insights from Large Animal Models

  2011cites this paper
• Tissue Factor, Blood Coagulation, and Beyond: An Overview

  2011cites this paper
• A Novel Experimental Animal Model of Arterial Stenosis Based on Endovascular Radiofrequency Energy Application

  2011cites this paper
• Modelo experimental de reestenose intrastent em artérias coronárias de suínos: efeito do implante de stent sobredimensionado

  2010cites this paper
• Thrombin Receptor Modulators: Medicinal Chemistry, Biological Evaluation, and Clinical Application

  2009cites this paper
• Developing a novel rabbit model of atherosclerotic plaque rupture and thrombosis by cold-induced endothelial injury

  2009cites this paper
• Simple rabbit model of vulnerable atherosclerotic plaque.

  2009cites this paper
• Animal Models for Atherosclerosis, Restenosis, and Endovascular Aneurysm Repair

  2008cites this paper
• Models of Behavior

  2008cites this paper
• Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity.

  2008cites this paper
• Protocolo experimental de indução de proliferação neointimal vascular em modelo de arterias coronárias suínas

  2008cites this paper
• Biomarkers and Bioassays for Cardiovascular Diseases: Present and Future

  2008cites this paper
• Increased Intrathecal Chemokine Receptor CCR2 Expression in Multiple Sclerosis.

  2007cites this paper
• Postinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow‐derived progenitor cells expressing membrane‐tethered anticoagulant fusion proteins

  2006cites this paper
• Crosstalk between thrombosis and inflammation in lung reperfusion injury.

  2006cites this paper
• Tissue factor upregulation drives a thrombosis–inflammation circuit in relation to cardiovascular complications

  2006cites this paper
• Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit.

  2006cites this paper
• Annexin A5 Down-regulates Surface Expression of Tissue Factor

  2005cites this paper
• Tissue factor mediates inflammation.

  2005cites this paper
• Vascular alterations in response to air desiccation injury in the carotid artery of the C3H/HeJ mouse.

  2005cites this paper
• Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity.

  2004cites this paper
• Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration

  2004cites this paper
• Insights into the Redox Control of Blood Coagulation: Role of Vascular NADPH Oxidase-Derived Reactive Oxygen Species in the Thrombogenic Cycle

  2004cites this paper
• Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.

  2004cites this paper
• Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosclerotic rabbits.

  2003cites this paper
• Atherosclerotic plaque rupture: local or systemic process?

  2003cites this paper
• Nonfatal Plaque Rupture , Intraplaque Hemorrhage , and Plaque Growth

  2003cites this paper
• MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury.

  2003cites this paper
• The Role of the Tissue Factor-Thrombin Pathway in Cardiac Ischemia-Reperfusion Injury

  2003cites this paper
• Prolonged procoagulant activity on overstretch‐injured coronary arteries in pigs

  2003cites this paper
• Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury.

  2003cites this paper
• The Impact of Heparin Compounds on Cellular Inflammatory Responses: A Construct for Future Investigation and Pharmaceutical Development

  2003cites this paper
• Angioplasty : A Potential Role of Tissue Factor Dietary Lipid Lowering Modifies Plaque Phenotype in Rabbit Atheroma After

  2003cites this paper
• Vascular gene delivery of anticoagulants by transplantation of retrovirally-transduced endothelial progenitor cells.

  2003cites this paper
• NADPH Oxidase Mediates Tissue Factor–Dependent Surface Procoagulant Activity by Thrombin in Human Vascular Smooth Muscle Cells

  2002cites this paper
• Vulnerable atherosclerotic plaque: emerging challenge for animal models

  2002cites this paper
• Antithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIa: An Ex Vivo Human Study

  2002cites this paper
• Artery Balloon Angioplasty Model B Significantly Contributes to Lumen Loss in a Rabbit Iliac κ Activation of Nuclear Factor

  2002cites this paper
• Tissue factor and coronary artery disease.

  2002cites this paper
• How to evaluate plaque vulnerability in animal models of atherosclerosis?

  2002cites this paper
• Non-hemostatic activity of coagulation factor Xa: potential implications for various diseases.

  2001cites this paper
• Comparative trial of local pharmacotherapy with L-arginine, r-hirudin, and molsidomine to reduce restenosis after balloon angioplasty of stenotic rabbit iliac arteries.

  2001cites this paper
• Local Delivery of Enoxaparin to Decrease Restenosis After Stenting: Results of Initial Multicenter Trial: Polish-American Local Lovenox NIR Assessment Study (The POLONIA Study)

  2001cites this paper
• Tissue factor as a therapeutic target in coronary syndromes.

  2001cites this paper
• CHAPTER 54 – Coronary Atherosclerosis and Restenosis

  2001cites this paper
• Lepirudin blunts endotoxin-induced coagulation activation.

  2000cites this paper
• Remodelado del trombo: punto clave en la progresión de la aterosclerosis coronaria

  2000cites this paper
• Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts.

  2000cites this paper
• Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty.

  2000cites this paper
• Release of active tissue factor by human arterial smooth muscle cells.

  2000cites this paper
• The mechanisms of coronary restenosis: insights from experimental models

  2000cites this paper
• Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation.

  2000cites this paper
• Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs.

  1999cites this paper
• Expression of Tissue Factor in Experimental Anastomotic Pseudoaneurysm

  1999cites this paper
• Heparin blunts endotoxin-induced coagulation activation.

  1999cites this paper